pd 98059 has been researched along with Gasser Syndrome in 1 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jandhyala, DM | 1 |
| Ahluwalia, A | 1 |
| Schimmel, JJ | 1 |
| Rogers, AB | 1 |
| Leong, JM | 1 |
| Thorpe, CM | 1 |
1 other study available for pd 98059 and Gasser Syndrome
| Article | Year |
|---|---|
Activation of the Classical Mitogen-Activated Protein Kinases Is Part of the Shiga Toxin-Induced Ribotoxic Stress Response and May Contribute to Shiga Toxin-Induced Inflammation.
Topics: Animals; Butadienes; Cell Line; Enterohemorrhagic Escherichia coli; Enzyme Activation; Epithelial Ce | 2016 |